RxDoctor Payments Data

Sarah Wheat, MD

Hospitalist · Bossier City, LANPI 1558571893

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AbbVie at 27.6% of the total. Reporting peaked in 2021 at $300 and has fallen 60.2% since, to $119 in 2025.

$905in general payments, 2019–2025

Across 18 payments — averaging $50.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$250
  • AstraZeneca$140
  • Shionogi Inc$119
  • Penumbra, Inc.$115
  • La Jolla Pharmaceutical Company$94
  • E.r. Squibb & Sons, L.L.C.$66
  • plus $121 from 4 others

What the payments were for

  • Food & beverage$905100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$905 in reported general payments places this provider in the 80th percentile of 301 hospitalist providers in Louisiana.

See all hospitalist providers in Louisiana

Medicare billing

Part B allowed, 2024
$86,525
Medicare patients
319
Services billed
865

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefdinir30$317
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$276
Doxycycline Monohydrate20$202
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen21$129
Methylprednisolone13$98
Nifedipine ErNifedipine11$65
Prednisone13$18

Paid to pharmacies, not to this prescriber.

Other hospitalist in Bossier City

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →